Biomarin Pharmaceutical INC (BMRN) SEC Filings — 2025
19 SEC filings for Biomarin Pharmaceutical INC (BMRN) in 2025.
Filings
- BioMarin Pharmaceutical Files Current Report — 8-K · Dec 22, 2025
- BioMarin Pharmaceutical Inc. Files 8-K Report — 8-K · Dec 19, 2025
- BioMarin Pharma Reports Officer/Director Changes — 8-K · Dec 17, 2025
- BioMarin Swings to Q3 Loss on Soaring R&D, Revenue Up 3.7% — 10-Q · Oct 28, 2025
- BioMarin Pharmaceutical Inc. Files 8-K — 8-K · Oct 27, 2025
- BioMarin Pharmaceutical Inc. Files 8-K — 8-K · Oct 7, 2025
- BioMarin Pharma Announces Board & Executive Changes — 8-K · Aug 11, 2025
- BioMarin Q2 Revenue Jumps to $640M on Strong Product Sales — 10-Q · Aug 5, 2025
- BioMarin Pharmaceutical Inc. Files 8-K on Financials — 8-K · Aug 4, 2025
- BioMarin CFO Departs, New CFO Appointed — 8-K · Aug 1, 2025
- BioMarin Pharma Reports Director Changes and Officer Compensation Updates — 8-K · May 22, 2025
- BioMarin Pharmaceutical Inc. Files 8-K Report — 8-K · May 16, 2025
- BioMarin Pharmaceutical Q1 2025 Update — 10-Q · May 2, 2025
- BioMarin Pharmaceutical Inc. Files 8-K on Financials — 8-K · May 1, 2025
- BioMarin Pharma Executive Pay Details Revealed — DEF 14A · Apr 8, 2025
- BioMarin Pharmaceutical Files 8-K on Security Holder Rights — 8-K · Mar 3, 2025
- BioMarin Appoints New Chief Medical Officer and EVP — 8-K · Feb 24, 2025
- BioMarin Pharma Files 2024 Annual Report — 10-K · Feb 24, 2025
- BioMarin Pharmaceutical Inc. Files 8-K for Financial Reporting — 8-K · Feb 19, 2025